Innovative Diagnostics for Public Health

InBios International Inc. specializes in the design, development and manufacture of diagnostic devices for emerging infectious diseases and biothreats. Founded in 1996 in Seattle, WA, our superior quality products are accurate, easy to use and cost effective.

InBios offers an extensive catalog of life science reagents, along with a portfolio of more than 25 diagnostic products, including FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified.

Read More

New Diagnostic Products for Coronavirus

Available Now for Purchase: US FDA Emergency Use Authorized Smart DetectTM SARS-CoV-2 rRT-PCR Kit is a real-time RT-PCR test for the qualitative detection of nucleic acid from severe acute respiratory syndrome-related coronavirus 2 in human nasopharyngeal, anterior nasal, and mid-turbinate nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider.

Check our COVID-19 page frequently for status on new ELISA and POC serology tests and antigen detection kit in progress.

Click on the button below to be added to our mailing list for the latest updates.

Sign Up for InBios Email

Zika   •   Chikungunya   •   Dengue   •   West Nile   •   Japanese Encephalitis   •   Scrub Typhus   •   Visceral Leishmaniasis   •   Cutaneous Leishmaniasis   •   Chagas   •   Filariasis   •   Strongyloides   •   Leptospirosis   •   Melioidosis   •   Norovirus

Current Newsletter
View Past Newsletters
Sign Up for InBios Email